Superficial femoral lymph node dissection after positive sentinel lymphadenectomy for early-stage melanoma of the lower extremity

Annals of Plastic Surgery

Volumn 51, Issue 1, 2003, Pages 69-76

  Pu, Lee L Q ^b,c   Cruse, C Wayne ^a   Wells, Karen E ^a   Shons, Alan R ^a   Reintgen, Douglas S ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSULFAN BLUE;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMUR; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LEG DISEASE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MALE; MELANOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TUMOR RECURRENCE;

EID: 0038681644     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SAP.0000054183.71644.A2     Document Type: Article

References (25)

1. Reintgen D, Balch CM, Kirkwood J, Ross M. Recent advances in the care of the patient with malignant melanoma. Ann Surg. 1997;225:1-14.
2. Morton DL, Wen DR, Wong JH, et al. Technical detail of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
3. Reintgen D, Cruse CW, Wells KE, et al. The orderly progression of melanoma nodal metastases. Ann Surg. 1994;220:759-767.
4. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg. 1996;223:217-224.
5. Reintgen D, Conrad AJ. Detection of occult melanoma cells in sentinel lymph nodes and blood. Semin Oncol. 1997; 24:(S4.)11-15.
6. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976-983.
7. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma. Ann Surg. 1999;230:453-465.
8. Cascinelli N, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO melanoma program experience. Ann Surg Oncol. 2000;7:469-474.
9. Gennari R, Bartolomei M, Restori A, et al. Sentinel node localization in primary melanoma: preoperative dynamic lymphoscintigraphy, intraoperative gamma probe, and vital dye guidance. Surgery. 1999;126:19-25.
10. Pu LLQ, Cruse CW, Wells KE, et al. Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma of the lower extremity. Plast Reconstr Surg. 1999; 104:964-969.
11. Kamath D, Brobeil A, Stall A, et al. Cutaneous lymphatic drainage in patients with grossly involved nodal basins. Ann Surg Oncol. 1999;6:345-349.
12. Messina JL, Glass LF. Pathologic examination of the sentinel lymph node. J Fla Med Assoc. 1997;84:153-156.
13. Houghton A, Coit D, Bloomer W, et al. NCCN melanoma practice guidelines. Oncology. 1998;3:153-177.
14. Urist MM, Maddox WA, Kennedy JE, Balch CM. Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer. 1983;51: 2152-2156.
15. Baas PC, Koops HS, Hoekstra HJ, et al. Groin dissection in the treatment of lower-extremity melanoma. Arch Surg. 1992;127:281-286.
16. Borgstein P, Meijer S. Historical perspective of lymphatic tumor spread and the emergence of the sentinel node concept. Eur J Surg Oncol. 1998;24:85-95.
17. Haddad FF, Stall A, Messina J, et al. The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion. Ann Surg Oncol. 1999;6:144-149.
18. Starz H, Gerstel C, Buchels H, Balda BR. Two simple morphometric parameters permit a clinically relevant staging of the sentinel node metastases in malignant melanoma and Merkel cell carcinoma. Eur J Nucl Med. 1999;26S:68.
19. Joseph E, Brobeil A, Glass F, et al. Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg Oncol. 1998;2:119-125.
20. Thompson JF, McCarthy WH, Bosch CMJ, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res. 1995;5:255-260.
21. Wagner JD, Gordon MS, Chuang TY, et al. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer. 2000; 89:453-462.
22. Wagner JD, Corbett L, Park HM, et al. Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures. Plast Reconstr Surg. 2000;105: 1956-1966.
23. Morton DL, Ollila DW. Critical review of the sentinel node hypothesis. Surgery. 1999;126:815-819.
24. McMasters KM, Edwards MI, Ross SL, et al. Frequency of non-sentinel lymph node metastasis in melanoma. Ann Surg Oncol. 2002;9:137-141.
25. Wrightson WR, Wong SL, Edwards MJ, et al. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of non-sentinel nodes following completion lymphadenectomy. J Surg Res. 2001;98:47-51.